In addition, BC cell-derived IL-35 was observed to promote the secretion of the inhibitory cytokine IL-10 while significantly decreasing the production of Th1-type IFN-γ and Th17-type IL-17, and it was associated with an elevated expression of the inhibitory receptor CD73 on conventional T cells. This evidence concerns the gene IL10 and breast cancer.